Truist Securities Upgrades Gilead Sciences (GILD) to Buy
Truist Securities analyst Robyn Karnauskas upgraded Gilead Sciences (NASDAQ: GILD) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
